Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Why These 5 Stocks Are Rocketing Higher Amid a Tough Monday Market

Page 1 of 2

Major U.S stock indexes are down slightly on Monday amid weak manufacturing data and crumpling oil prices, however, shares of Eyegate Pharmaceuticals Inc (NASDAQ:EYEG), Amaya Inc (NASDAQ:AYA), TrovaGene Inc (NASDAQ:TROV), Companhia Energetica Minas Gerais (ADR) (NYSE:CIG), and Eros International plc (NYSE:EROS) are well in the green despite that. In the following article, we will examine why investors are buying these stocks and also examine the latest hedge fund activity in them.

While there are many metrics that investors can assess in the investment process, hedge fund sentiment is something that is often overlooked. However, hedge funds and other institutional investors allocate significant resources while making their bets and their long-term focus makes them the perfect investors to emulate. This is supported by our research, which determined that following the small-cap stocks that hedge funds are collectively bullish on can help a smaller investor beat the S&P 500 by around 95 basis points per month (see more details here).

Back to Monday’s gainers, we’ll start with Eyegate Pharmaceuticals Inc (NASDAQ:EYEG), which is up by over 91% in the early afternoon after analysts at Rodman & Renshaw initiated coverage on the stock with a price target of $10.00, which represented over 400% upside potential from its price entering the day’s trading session.

Unsurprisingly, the nano-cap company is not very popular among the funds we follow. Only two reported long positions in Eyegate Pharmaceuticals Inc (NASDAQ:EYEG) as of the end of September, both of which were initiated during the third quarter (the company went public during the quarter), and they amassed 4.2% of the float.

Follow Eyegate Pharmaceuticals Inc (NASDAQ:EYEG)
Trade (NASDAQ:EYEG) Now!

Moving on, Amaya Inc (NASDAQ:AYA) shares are up by 25% today after the company announced a non-binding proposal from CEO David Baazov. The buyout offer of CAD$21.00 per share (US$15.07) represented a 40% premium from the shares closing price on Friday. The Canadian company, which runs the online poker site PokerStars, will convene a special committee to evaluate the proposal. Out of the 730 funds that we track, 18 of them held shares of the company on September 30, amassing 27.4% of Amaya Inc (NASDAQ:AYA)’s float.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!